Search
Products
Community
Markets
News
Brokers
More
IN
Get started
Markets
/
Italy
/
ETF market
/
CBIO
/
Analysis
GLOBAL X CHINA BIOTECH UCITS ETF USD
CBIO
Euronext Milan
CBIO
Euronext Milan
CBIO
Euronext Milan
CBIO
Euronext Milan
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
News
Ideas
Technicals
Key stats
Assets under management (AUM)
1.04 M
EUR
Fund flows (1Y)
—
Dividend yield (indicated)
—
Discount/Premium to NAV
−0.02%
About GLOBAL X CHINA BIOTECH UCITS ETF USD
Issuer
Carne Global Financial Services Ltd.
Brand
Global X
Expense ratio
0.68%
Home page
globalxetfs.eu
Inception date
Jan 18, 2022
Index tracked
Solactive China Biotech Innovation Index
Management style
Passive
ISIN
IE0004LIBFM2
The investment objective of the Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive China Biotech v2 USD Index NTR
Show more
Classification
Asset Class
Equity
Category
Size and style
Focus
Total market
Niche
Broad-based
Weighting scheme
Market cap
Selection criteria
Market cap
Returns
1 month
3 months
Year to date
1 year
3 years
5 years
Price performance
—
—
—
—
—
—
NAV total return
—
—
—
—
—
—
What's in the fund
As of May 20, 2024
Exposure type
Stocks
Bonds, Cash & Other
Health Technology
Stocks
99.92%
Health Technology
99.92%
Bonds, Cash & Other
0.08%
Cash
0.08%
Corporate
0.00%
Stock breakdown by region
2%
97%
Asia
97.41%
North America
2.59%
Latin America
0.00%
Europe
0.00%
Africa
0.00%
Middle East
0.00%
Oceania
0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows